Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Shaman commences phase II trials of Provir in AIDS-related diarrhea

April 1, 1997

Kaken prepares broad-spectrum antiulcer agent

March 27, 1997

Axcan receives approvable letter for URSO from FDA

March 26, 1997

Synsorb Cd enters phase II

March 26, 1997

Daiichi Pharmaceutical presents novel antisecretory agent

March 25, 1997

Byk Canada begins operations

March 21, 1997

Gastric prokinetic agent developed by Kyorin

March 19, 1997

Fujisawa prepares PLA2 inhibitors

March 19, 1997

Combination therapy for idiopathic intractable hiccup

March 18, 1997

Oral and intravenous pharmacokinetics of SDZ-HTF-919 in humans

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...